FDA NDC Directory · JSON-LD · Markdown

doxorubicin hydrochloride

NDC 68001-707 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION, LIPOSOMAL

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA219199
Dosage form / routeINJECTION, SUSPENSION, LIPOSOMAL · INTRAVENOUS
Active ingredientsDOXORUBICIN HYDROCHLORIDE (2 mg/mL)
Marketing started20260710
Package count1

External sources

Source: openFDA. Public-domain (CC0).